ATE241584T1 - Verfahren zur selektiven abtrennung und reinigung von eicosapentaensäure und decosohexaensäure und deren estern - Google Patents

Verfahren zur selektiven abtrennung und reinigung von eicosapentaensäure und decosohexaensäure und deren estern

Info

Publication number
ATE241584T1
ATE241584T1 AT00113020T AT00113020T ATE241584T1 AT E241584 T1 ATE241584 T1 AT E241584T1 AT 00113020 T AT00113020 T AT 00113020T AT 00113020 T AT00113020 T AT 00113020T AT E241584 T1 ATE241584 T1 AT E241584T1
Authority
AT
Austria
Prior art keywords
acid
esters
decosohexaenic
purification
flowing
Prior art date
Application number
AT00113020T
Other languages
English (en)
Inventor
Satoshi Kiyohara
Shiro Fujita
Original Assignee
Nisshin Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Pharma Inc filed Critical Nisshin Pharma Inc
Application granted granted Critical
Publication of ATE241584T1 publication Critical patent/ATE241584T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • C07C51/47Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/48Separation; Purification; Stabilisation; Use of additives
    • C07C67/56Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Fats And Perfumes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT00113020T 1999-06-28 2000-06-21 Verfahren zur selektiven abtrennung und reinigung von eicosapentaensäure und decosohexaensäure und deren estern ATE241584T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18140799 1999-06-28

Publications (1)

Publication Number Publication Date
ATE241584T1 true ATE241584T1 (de) 2003-06-15

Family

ID=16100230

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00113020T ATE241584T1 (de) 1999-06-28 2000-06-21 Verfahren zur selektiven abtrennung und reinigung von eicosapentaensäure und decosohexaensäure und deren estern

Country Status (7)

Country Link
US (1) US6313330B1 (de)
EP (1) EP1065196B1 (de)
AT (1) ATE241584T1 (de)
CA (1) CA2311974A1 (de)
DE (1) DE60002952T2 (de)
DK (1) DK1065196T3 (de)
NO (1) NO321273B1 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101167331B1 (ko) 2003-12-30 2012-07-19 디에스엠 아이피 어셋츠 비.브이. 탈기 방법
BRPI0613358A8 (pt) * 2005-07-08 2017-12-26 Dsm Ip Assets Bv ácidos de gordura poli - insaturada para o tratamento da demência e condições relacionadas à pré-demência
JP2010532418A (ja) 2007-06-29 2010-10-07 マーテック バイオサイエンシーズ コーポレーション 多価不飽和脂肪酸のエステルの製造方法および精製方法
WO2010028067A1 (en) 2008-09-02 2010-03-11 Amarin Corporation Plc Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same
JP5503856B2 (ja) 2008-09-10 2014-05-28 キユーピー株式会社 高度不飽和脂肪酸誘導体の取得方法
DK2429317T4 (da) 2009-04-17 2019-05-13 Natac Pharma S L Sammensætninger med højt indhold af omega-3-fedtsyrer og med lavt indhold af phytansyre
SG175390A1 (en) 2009-04-29 2011-12-29 Amarin Corp Plc Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
PT3278665T (pt) 2009-04-29 2020-11-19 Amarin Pharmaceuticals Ie Ltd Composição farmacêutica estável e métodos de utilização das mesmas
CN106074486A (zh) 2009-06-15 2016-11-09 阿马里纳药物爱尔兰有限公司 在相伴他汀类疗法的对象中降低甘油三酯、没有增加ldl‑c水平的组合物和方法
US20110071176A1 (en) 2009-09-23 2011-03-24 Amarin Pharma, Inc. Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
PE20130491A1 (es) * 2009-12-30 2013-05-02 Basf Pharma Callanish Ltd Proceso simulado de separacion cromatografica de lecho movil para la purificacion de acidos grasos poliinsaturados
NZ778131A (en) 2010-11-29 2023-03-31 Amarin Pharmaceuticals Ie Ltd Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
GB201111589D0 (en) 2011-07-06 2011-08-24 Equateq Ltd New modified process
GB201111591D0 (en) 2011-07-06 2011-08-24 Equateq Ltd Further new process
GB201111595D0 (en) 2011-07-06 2011-08-24 Equateq Ltd Improved process
GB201111594D0 (en) 2011-07-06 2011-08-24 Equateq Ltd New improved process
GB201111601D0 (en) 2011-07-06 2011-08-24 Equateq Ltd New process
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
EP2775837A4 (de) 2011-11-07 2015-10-28 Amarin Pharmaceuticals Ie Ltd Verfahren zur behandlung von hypertriglyceridämie
ES2891473T3 (es) 2012-01-06 2022-01-28 Amarin Pharmaceuticals Ie Ltd Composiciones y métodos para reducir los niveles de alta sensibilidad (hs-CRP) en un sujeto
EP4338805B1 (de) 2012-06-29 2025-06-04 Amarin Pharmaceuticals Ireland Limited Eicosapentaensäureethylester zur verwendung bei der verringerung des risikos eines nicht-fatalen herzinfarktes bei einer person in statin-therapie
WO2014074552A2 (en) 2012-11-06 2014-05-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
US9814733B2 (en) 2012-12-31 2017-11-14 A,arin Pharmaceuticals Ireland Limited Compositions comprising EPA and obeticholic acid and methods of use thereof
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
GB201300354D0 (en) 2013-01-09 2013-02-20 Basf Pharma Callanish Ltd Multi-step separation process
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US9662307B2 (en) 2013-02-19 2017-05-30 The Regents Of The University Of Colorado Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
US9283201B2 (en) 2013-03-14 2016-03-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for treating or preventing obesity in a subject in need thereof
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US9428711B2 (en) 2013-05-07 2016-08-30 Groupe Novasep Chromatographic process for the production of highly purified polyunsaturated fatty acids
US8802880B1 (en) 2013-05-07 2014-08-12 Group Novasep Chromatographic process for the production of highly purified polyunsaturated fatty acids
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
CN103962091B (zh) * 2013-11-28 2017-01-25 大连工业大学 一种银离子改性氨基硅胶分离epa和dha的方法
EP2883860B1 (de) 2013-12-11 2016-08-24 Novasep Process Chromatografisches Verfahren zur Herstellung von mehrfach ungesättigten Fettsäuren
JP6303017B2 (ja) 2014-01-07 2018-03-28 ノヴァセプ プロセスNovasep Process 芳香族アミノ酸を精製する方法
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
WO2015195662A1 (en) 2014-06-16 2015-12-23 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
WO2018213663A1 (en) 2017-05-19 2018-11-22 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
KR20210110890A (ko) 2018-09-24 2021-09-09 애머린 파마슈티칼스 아일랜드 리미티드 대상체에서 심혈관 사건의 위험도를 감소시키는 방법
JP7528054B2 (ja) * 2019-03-26 2024-08-05 日清ファルマ株式会社 エイコサペンタエン酸アルキルエステル含有組成物の製造方法
CN109912403A (zh) * 2019-04-18 2019-06-21 南京市第一医院 一种Omega-3制备大电导钙激活钾通道开放剂的方法
US12427134B2 (en) 2019-11-12 2025-09-30 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of cardiovascular events in a subject with atrial fibrillation and/or atrial flutter
AU2022263358A1 (en) 2021-04-21 2023-11-30 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of heart failure

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0347509A1 (de) * 1988-06-21 1989-12-27 Century Laboratories Inc. Verfahren zur Extraktion und Reinigung von polyungesättigten Fettsäuren aus Naturquellen
JPH028298A (ja) * 1988-06-17 1990-01-11 Agency Of Ind Science & Technol イカ内臓からドコサヘキサエン酸及びエイコサペンタエン酸を選択的に分離精製する方法
JPH07242895A (ja) * 1993-03-16 1995-09-19 Ikeda Shiyotsuken Kk 高純度エイコサペンタエン酸又はその低級アルコールエステルの分離精製法
JPH09151390A (ja) * 1995-11-30 1997-06-10 Bizen Kasei Kk 高度不飽和脂肪酸及びその誘導体の精製方法
JPH10310551A (ja) * 1997-05-12 1998-11-24 Nippon Wax Polymer Kaihatsu Kenkyusho:Kk エイコサペンタエン酸又はそのエステルの精製方法

Also Published As

Publication number Publication date
DK1065196T3 (da) 2003-09-22
EP1065196B1 (de) 2003-05-28
EP1065196A1 (de) 2001-01-03
NO20003335L (no) 2000-12-29
NO321273B1 (no) 2006-04-10
US6313330B1 (en) 2001-11-06
DE60002952D1 (de) 2003-07-03
CA2311974A1 (en) 2000-12-28
DE60002952T2 (de) 2004-03-11
NO20003335D0 (no) 2000-06-26

Similar Documents

Publication Publication Date Title
ATE241584T1 (de) Verfahren zur selektiven abtrennung und reinigung von eicosapentaensäure und decosohexaensäure und deren estern
JP5951764B2 (ja) 魚油から高純度のepaを生成するためのsmb方法
JP5990580B2 (ja) 新規なsmb方法
JP5990267B2 (ja) 改善されたsmb方法
JP5946833B2 (ja) ω3脂肪酸を濃縮する方法
ATE110103T1 (de) Verfahren zur extraktion von docosahexaensäureethylester aus fischölen und docosahexaen- und eicosapentaensäureethylester enthaltende pharmazeutische und/oder diät- zusammensetzungen.
DE59409712D1 (de) Verfahren zur chromatographischen reinigung und trennung von nucleinsäuregemischen
ATE224352T1 (de) Verfahren zum herstellen von fettsäureester
JP2014518312A (ja) Smb方法
DK1106602T3 (da) Kromatografisk simulated moving bed-oprensning af aminosyrer
DE69423027D1 (de) Verfahren zum Herstellen von Essigsäureestern aus Methanol
DE59304941D1 (de) Verfahren zum Abtrennen von Aminosäuren aus wässrigen Lösungen
ES2905647T3 (es) Proceso para la producción de ácido graso altamente insaturado de una pureza alta con un rendimiento alto
JPH04218596A (ja) 高度不飽和脂肪酸類の選択的取得方法
DE69013092D1 (de) Verfahren zur Isolation von Hydroxyfettsäurederivaten aus Convolvulaceae-Pflanzen.
DE58904353D1 (de) Verfahren zur herstellung von methacrylsaeure durch oxidation von methacrolein.
ATE169611T1 (de) Verfahren zur phosgenierung in gegenwart des acetonitrils
DE69505347D1 (de) Verfahren zum Reinigen von alpha,beta-ungesättigten Estern
EP1918270A4 (de) Verfahren zur aufreinigung von ubiquinon-10
ATE395428T1 (de) Verfahren zur isolierung und reinigung von lipidezellwandkomponenten
DE59201724D1 (de) Verfahren zur Herstellung von höheren Alkoholen durch katalytische Hydrierung von Carbonsäurealkylestern.
DE68928249D1 (de) Verfahren zur Trennung von Methylester von alpha-L-aspartyl-L-phenylalaninen
KR900701982A (ko) 지방산 에스테르, 지방 및 지방산의 수소화 방법 및 이 방법을 수행하는 장치
DE69524565D1 (de) Verfahren zur Rückgewinnung der Carbonsäuren aus wässrigen Lösungen
JPS5786254A (en) Healthful food

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties